Results 31 to 40 of about 2,572,587 (193)

Intraperitoneal insulin infusion: on the way to the artificial pancreas

open access: yesСахарный диабет, 2015
Creating an "artificial pancreas" (a "closed loop" insulin pump, with self-adjusting insulin abilities, based on real time continuous glucose monitoring data) – is one of the most actual medical challenges of modern engineering and cybernetics.Artificial
Vladimir Aleksandrovich Karpel'ev   +4 more
doaj   +1 more source

A Continuous Subcutaneous Insulin Infusion Needle Break [PDF]

open access: yesClinical Diabetes, 2015
### Adverse Event Our patient was 13 years and 2 months old, a white boy with type 1 diabetes diagnosed 2 years and 5 months before this adverse event (AE). He had no other significant medical history. His A1C was 7.6% 1 month before the insulin infusion needle break event.
George, Minu M.   +2 more
openaire   +2 more sources

Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes

open access: yesThe Scientific World Journal, 2013
Aim. Continuous subcutaneous insulin infusion (CSII) is used as an option in patients with diabetes failing to multiple daily injections (MDI). Psychological factors may play a relevant role in the failure to attain therapeutic goals in patients on MDI ...
Francesco Rotella   +5 more
doaj   +1 more source

PERINATAL OUTCOMES OF PREGNANT WOMEN WITH TYPE 1 DIABETES MELLITUS: COMPARISON OF MULTIDOSE INJECTION AND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION

open access: yes, 2020
Objective. To evaluate obstetric and neonatal outcomes of patients with type 1 diabetes mellitus (T1DM) and compare multidose injection (MDI) and continuous subcutaneous insulin infusion (CSII)
Fadiloglu, E.   +3 more
core   +1 more source

Use of Sensors in the Treatment and Follow-up of Patients with Diabetes Mellitus

open access: yesSensors, 2010
Glucose control is the cornerstone of Diabetes Mellitus (DM) treatment. Although self-regulation using capillary glycemia (SRCG) still remains the best procedure in clinical practice, continuous glucose monitoring systems (CGM) offer the possibility of ...
Manuel Aguilar-Diosdado   +4 more
doaj   +1 more source

Estimation of insulin sensitivity from continuous glucose monitoring and insulin pump data in type 1 diabetes [PDF]

open access: yes, 2012
Diabetes mellitus is a disease characterized by chronic hyperglycemia either due to a lack of secretion of the hormone insulin (Type 1 Diabetes Mellitus, T1DM) or due to impaired action of this hormone (Type 2 Diabetes Mellitus, T2DM).
Ronca, Gabriele
core  

RilstoneTable_S1 – Supplemental material for A Pilot Study of Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion (CSII) in Adults with Type 1 Diabetes (FIRST1D)

open access: yes, 2020
Supplemental material, RilstoneTable_S1 for A Pilot Study of Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion (CSII) in Adults with Type 1 Diabetes (FIRST1D) by Siân Rilstone, Monika Reddy and Nick Oliver in Journal ...
Siân Rilstone (8481303)   +2 more
core   +1 more source

Case Report: Subcutaneous sensor-augmented insulin pump therapy in a 510-g preterm infant with hyperglycemia

open access: yesFrontiers in Pediatrics
Neonatal hyperglycemia affects up to 80% of extremely low birth weight (ELBW) infants and is independently associated with mortality, intraventricular hemorrhage, and adverse neurodevelopmental outcomes.
Christian Schlunk   +4 more
doaj   +1 more source

Long-Term Benefits of an Integrated Continuous Glucose Monitoring and Insulin Pump System for Emergency Admissions, Hospitalization, and Metabolic Control in a Cohort of People With Diabetes: Retrospective Cohort Study

open access: yesJMIR Diabetes, 2023
BackgroundThere is evidence in the literature that the use of sensor-augmented insulin pumps in patients with high-complexity diabetes improves metabolic control.
Miguel O'Meara   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy